DanCann Pharma A/S publishes Q3-2022 report
COPENHAGEN, Denmark, 04 November 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by cannabinoids, hereby announce that the Company has published its report for the third quarter of 2022. The Q3-2022 report is available as an attached document to this press release and at www.dancann.com.Group key figures Q3-2022: KDKK 01/01/22 01/01/21 01/07/22 01/04/21 01/01/21 30/09/22 30/09/21 30/09/22 30/09/21 31/12/21Net sales 3,606 0 1,569 0 874